臺灣人文及社會科學引文索引資料庫系統

:::

詳目顯示

回上一頁
第 1 筆 / 總合 1 筆   第一頁 上一頁 下一頁 最後一頁
/1頁
題名：臺灣2025年C肝消除的策略與進度
書刊名：臺灣公共衛生雜誌
作者：吳慧敏／楊雯雯／劉嘉玲／鄭國本／陳時中／陳建仁／蒲若芳
作者(外文)：Wu, Grace Hui-min／Yang, Wen-wen／Liu, Chia-ling／Cheng, Kuo-pen／Chen, Shih-chung／Chen, Chien-jen／Pwu, Raoh-fang
出版日期：2021
卷期：40:1
頁次：頁1-4
主題關鍵詞：C型肝炎；C肝口服新藥；防治策略
原始連結：連回原系統網址new window
相關次數：
  • 被引用次數被引用次數:期刊(1) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:1
  • 共同引用共同引用:0
  • 點閱點閱:6
期刊論文
1.Sun, C. A.、Chen, H. C.、Lu, S. N.(2001)。Persistent hyperendemicity of hepatitis c virus infection in Taiwan: The important role of iatrogenic risk factors。Journal of Medical Virology，65，30-34。  new window
2.Wang, J. T.、Wang, T. H.、Lin, J. T.、Lee, C. Z.、Sheu, J. C.、Chen, D. S.(1995)。Effect of hepatitis C antibody screening in blood donors on post-transfusion hepatitis in Taiwan。J Gastroenterol Hepatol，10，454-458。  new window
3.Liu, Jyh‐You、Lin, Hsi‐Hsun、Liu, Yung‐Ching(2008)。Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan。Clinical Infectious Diseases，46，1761-1768。  new window
4.Ng, Mei-Hing、Chou, Jen-Yu、Chang, Ta-Jen(2013)。High prevalence but low awareness of hepatitis C virus infection among heroin users who received methadone maintenance therapy in Taiwan。Addictive Behaviors，38，2089-2093。  new window
5.Chiang, C. J.、Yang, Y. W.、You, S. L.、Lai, M. S.、Chen, C. J.(2013)。Thirty-year outcomes of the national hepatitis B immunization program in Taiwan。JAMA，310，974-976。  new window
6.Chen, Ding-Shinn(2019)。Taiwan commits to eliminating hepatitis C in 2025。Lancet Infectious Diseases，19，466-467。  new window
7.Wu, Grace Hui-min、Pwu, Raoh-fang、Chen, Shih-chung(20181200)。Achieving Hepatitis C Elimination in Taiwan--Overcoming Barriers by Setting Feasible Strategies。Journal of the Formosan Medical Association，117(12)，1044-1045。  new window
8.Cox, A. L.、El-Sayed, M. H.、Kao, J. H.(2020)。Progress towards elimination goals for viral hepatitis。Nat Rev Gastroenterol Hepatol，17，533-542。  new window
9.Chen, T. Z.、Wu, J. C.、Yen, F. S.(1995)。Injection with nondisposable needles as an important route for transmission of acute community-acquired hepatitis C virus infection in Taiwan。J Med Virol，46(3)，247-251。  new window
10.Ho, M. S.、Hsu, C. P.、Yuh, Y.、King, C. C.、Tsai, J. F.、Mau, Y. C.、Hsu, L. C.、Chao, W. H.(1997)。High rate of hepatitis C virus infection in an isolated community: persistent hyperendemicity or period-related phenomena?。J Med Virol，52(4)，370-376。  new window
11.Li, Chia-Wen、Yang, Chia-Jui、Sun, Hsin-Yun(2018)。Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan。PLoS One，13。  new window
12.Razavi, Homie、Gonzalez, Yuri Sanchez、Yuen, Cammy、Cornberg, Markus(2020)。Global timing of hepatitis C virus elimination in high-income countries。Liver International，40(3)，522-529。  new window
13.劉嘉玲、楊雯雯、吳慧敏、鄭國本、蒲若芳(2019)。台灣C型肝炎消除的國家政策與軌跡。愛之關懷季刊，109，6-16。  延伸查詢new window
14.Wu, Grace Hui‐Min、Pwu, Raoh‐Fang、Chen, Shih‐Chung、Chen, Ding‐Shinn(2020)。Taiwan is on track of accelerating hepatitis C elimination by 2025。Liver International，40，1506-1507。  new window
15.Razavi, Homie、Gonzalez, Yuri Sanchez、Yuen, Cammy、Cornberg, Markus(2020)。Response to Taiwan is on track of accelerating hepatitis C elimination by 2025。Liver International，40，1507。  new window
16.Huang, M. H.、Chang, S. Y.、Liu, C. H.(2019)。HCV reinfections after viral clearance among HIV-positive patients with recent HCV infection in Taiwan。Liver Int，39(10)，1860-1867。  new window
17.Chiang, C. J.、Yang, Y. W.、Chen, J. D.(2015)。Significant reduction in end-stage liver diseases burden through the national viral hepatitis therapy program in Taiwan。Hepatology，61，1154-1162。  new window
18.Liu, C. H.、Liu, C. J.、Lin, C. L.(2008)。Pegylated interferon-alpha-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trial。Clin Infect Dis，47，1260-1269。  new window
19.Yu, M. L.、Dai, C. Y.、Huang, J. F.(2008)。Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: a randomized trial。Hepatology，47，1884-1893。  new window
20.Yu, M. L.、Dai, C. Y.、Huang, J. F.(2007)。A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C。Gut，56，553-559。  new window
21.Wang, C. S.、Chang, Ting-Tung、Chou, P.(1998)。Differences in risk factors for being either a hepatitis B carrier or anti-hepatitis C+ in a hepatoma-hyperendemic area in rural Taiwan。Journal of Clinical Epidemiology，51(9)，733-738。  new window
會議論文
1.Chen, C. J.、Chuang, W. L.、Lee, M. H.(2016)。Disease burden of chronic hepatitis C virus (HCV) infection in Taiwan。The 25th Asian Pacific Association for the Study of the Liver (APASL)。  new window
研究報告
1.衛生福利部。國家消除C肝辦公室統計資訊。  延伸查詢new window
圖書
1.國家消除C肝政策綱領編輯團隊(2019)。國家消除C肝政策綱領2018-2025。衛生福利部。  延伸查詢new window
其他
1.WHO。Global health sectors strategy on viral hepatitis 2016-2021: towards ending viral hepatits，https://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/。  new window
2.CDA Foundation。Polaris-Hep C，http:// cdafound.org/polaris/。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
QR Code
QRCODE

臺灣人文及社會科學引文索引資料庫

目前上線人數：1170（臺灣：1164，外國：6） ／ 本年度總使用人次：2017497 ／ 訪客人次（自102年09月）：67832359
國家圖書館著作權聲明 Copyright © 2013 All rights reserved.
本館地址: 100201臺北市中山南路20號． 本館地圖及交通資訊．
總機：(02)23619132．最佳瀏覽解析度為1024x768以上